Lazard's Healthcare Hire: A Shot in the Arm?
Update: 2025-09-18
Description
Lazard stock jumps as biopharma heavyweight Dr. Geoffrey Porges joins as Managing Director! Find out how this strategic hire, coupled with a Federal Reserve interest rate cut, fueled investor optimism and a 2.7% stock surge. Is Lazard a buy now? We break down the company's volatile year, impressive 5-year growth, and what this move means for the future of healthcare investing.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
